Literature DB >> 8192474

Identification of TEM-26 beta-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae.

C Urban1, K S Meyer, N Mariano, J J Rahal, R Flamm, B A Rasmussen, K Bush.   

Abstract

An epidemic of nosocomial ceftazidime-resistant Klebsiella pneumoniae was correlated with production of a ceftazidime-hydrolyzing enzyme with an isoelectric point of 5.6 (BMH-1). BMH-1 was encoded on a large transferable plasmid conferring multiple antibiotic resistance. The gene that encodes BMH-1 was identical to the gene that encodes the TEM-26 extended-spectrum beta-lactamase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8192474      PMCID: PMC284466          DOI: 10.1128/AAC.38.2.392

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

Review 1.  Classification of beta-lactamases: groups 2c, 2d, 2e, 3, and 4.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

Review 2.  Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

3.  Biochemical characteristics of extended broad spectrum beta-lactamases.

Authors:  K Bush; S B Singer
Journal:  Infection       Date:  1989 Nov-Dec       Impact factor: 3.553

4.  Effective cooling allows sonication to be used for liberation of beta-lactamases from gram negative bacteria.

Authors:  K Bush; S B Singer
Journal:  J Antimicrob Chemother       Date:  1989-07       Impact factor: 5.790

5.  Variations between the nucleotide sequences of Tn1, Tn2, and Tn3 and expression of beta-lactamase in Pseudomonas aeruginosa and Escherichia coli.

Authors:  S T Chen; R C Clowes
Journal:  J Bacteriol       Date:  1987-02       Impact factor: 3.490

Review 6.  Extended-spectrum beta-lactamases.

Authors:  A Philippon; R Labia; G Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

7.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

Authors:  V Jarlier; M H Nicolas; G Fournier; A Philippon
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

8.  Sequences of MGH-1, YOU-1, and YOU-2 extended-spectrum beta-lactamase genes.

Authors:  L B Rice; S H Marshall; L L Carias; L Sutton; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

9.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases.

Authors:  A Mathew; A M Harris; M J Marshall; G W Ross
Journal:  J Gen Microbiol       Date:  1975-05

10.  Effect of fructose and other carbohydrates on the surface properties, lipoteichoic acid production, and extracellular proteins of Streptococcus mutans Ingbritt grown in continuous culture.

Authors:  L Hardy; N A Jacques; H Forester; L K Campbell; K W Knox; A J Wicken
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

View more
  23 in total

1.  BetalasEN: microdilution panel for identifying beta-lactamases present in isolates of Enterobacteriaceae.

Authors:  Christine C Sanders; Anton F Ehrhardt; Ellen Smith Moland; Kenneth S Thomson; Barbara Zimmer; Darcie E Roe
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

Review 2.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates.

Authors:  J Kohler; K L Dorso; K Young; G G Hammond; H Rosen; H Kropp; L L Silver
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

4.  Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains causing nosocomial outbreaks of infection in the United Kingdom.

Authors:  K Shannon; P Stapleton; X Xiang; A Johnson; H Beattie; F El Bakri; B Cookson; G French
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

5.  Survey of Klebsiella pneumoniae producing extended-spectrum beta-lactamases: prevalence of TEM-3 and first identification of TEM-26 in France.

Authors:  M J Soilleux; A M Morand; G J Arlet; M R Scavizzi; R Labia
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

Review 6.  Is it important to identify extended-spectrum beta-lactamase-producing isolates?

Authors:  K Bush
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-05       Impact factor: 3.267

7.  Comparison of culture media for detection of Acinetobacter baumannii in surveillance cultures of critically-ill patients.

Authors:  A O Ajao; G Robinson; M S Lee; T D Ranke; R A Venezia; J P Furuno; A D Harris; J K Johnson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

Review 8.  Epidemiology of β-Lactamase-Producing Pathogens.

Authors:  Karen Bush; Patricia A Bradford
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

9.  Molecular epidemiology of Enterobacteriaceae isolates producing extended-spectrum beta-lactamases in a French hospital.

Authors:  Jean-Philippe Lavigne; Nicole Bouziges; Catherine Chanal; Aba Mahamat; Sylvie Michaux-Charachon; Albert Sotto
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

10.  Outbreak of ceftazidime-resistant Klebsiella pneumoniae in a pediatric hospital in Warsaw, Poland: clonal spread of the TEM-47 extended-spectrum beta-lactamase (ESBL)-producing strain and transfer of a plasmid carrying the SHV-5-like ESBL-encoding gene.

Authors:  M Gniadkowski; A Palucha; P Grzesiowski; W Hryniewicz
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.